A novel intradermal combination vaccine for PCV2 and Mycoplasma hyopneumoniae protection in swine: its use with Lawsonia intracellularis and PRRSV vaccines

Table 2 Seropositivity to PRRSV pre-vaccination (SD0), pre-challenge (SD27) and end of study (SD56), Area-Under-the-curve (AUC), and average daily weight gain post-challenge (SD27 – SD56)

Group	% seropositive to PRRSV antibodies			PRRSV Viraemia	ADWG (g) [st.dev.]^*
Group	SD0	SD27	SD56	Mean AUC^*	ADWG (g) [st.dev.]^*
PRRS-G1: PCV M Hyo ID w/LFD ID + PRRS ID	0.0	67.0	100.0	26.1^{a, b} [± 19.5]	812^a [± 129]
PRRS-G2: PRRS ID	0.0	100.0	100.0	9.0^a [± 7.3]	859^a [± 86]
PRRS-G3: Not vaccinated	0.0	0.0	93.0	49.8^b [± 9.8]	655^b [± 61]

* Values with different superscripts are significantly different from each other (p < 0.0001)

ISSN: 2055-5660